#Epstein barr virus

[iammadelinepod]

Someone help me make this lovely graphic. The QR code takes you to the #GoFundMe please share. Some Media links(for verification) in the GoFundMe and in this profile. Most recent can be found in this Twitter link which can be shared on Facebook and Instagram (for those who don't know apparently Google and Facebook and Instagram are mad at each other in Canada so you can't share news articles)

[myso-podlife]

https://pca.st/episode/d26e002a-22c6-49d7-8a06-4f70c2a7709b

[definitely-cursed]

On today’s game of How Will My Chronic Illness Manifest Today? We have special guest star, RASH!

Rash had humble beginnings, starting on one cheek last night, but has since blown up and expanded their empire across the face, down the neck, and all the way to the ends of the arms! Rash says their plans for the future include spreading onto the back, which OP can verify is starting to get itchy!

Which random ailment will affect OP next? Place your bets now!

[mindblowingscience]

Epstein-Barr virus, a common virus that infects most people at some point in their lives, has long been suspected as a trigger of multiple sclerosis, an autoimmune disease affecting around 36 people in every 100,000 worldwide. But exactly how this virus trips the immune system into attacking the body's own cells, often years later, has mostly eluded scientists.

Continue Reading.

[x2oxenfree]

[restless-soulz]

why isn’t EBV a chronic condition?

genuinely asking here because I had a massive flare up for a few months and even though it’s abating, it still has bad days that really impact me on a day to day basis and there not much I can do about it. It’s already impacted my life in s lot of ways and I’ve had skip out on s lot of opportunities because I (correctly) assumed that I wouldn’t have enough energy to stay awake never mind pull on a mask and being social. It’s been months and I can feel like it’s gonna linger for the rest of my life. And it will stay with me the rest of my life.

[medicomunicare]

Neo-autoantigeni: il bersaglio primario dei linfociti T auto-reattivi nel lupus sistemico

Le malattie autoimmuni sono diffuse e notoriamente difficili da curare. In parte, questo è dovuto al fatto che il motivo per cui il sistema immunitario attacca i propri tessuti nei pazienti con queste condizioni rimane poco chiaro. Le malattie autoimmuni si sviluppano quando il sistema immunitario del corpo attacca per errore i propri tessuti invece di combattere invasori stranieri come batteri o…

[aimarketresearch]

Epstein-Barr Virus Drug Market Size, Share, Trends, Demand, Growth and Competitive Analysis

Epstein-Barr Virus Drug Market research report has been prepared with the systematic gathering and evaluation of market information for  industry which is presented in a form that explains various facts and figures to the business. Report saves valuable time as well as adds credibility to the work that is performed to grow business. This quality report has been planned with full commitment and transparency in research and analysis. With the systematic insights of this report, companies can self-assuredly take decisions about the production and marketing strategies. Epstein-Barr Virus Drug Market document provides the same by studying the market and the  industry with respect to numerous aspects.

Epstein-Barr Virus Drug Market report gives explanation about the different segments of the market analysis which is demanded by today’s businesses. Key players are taking actions such as developments, product launches, acquisitions, mergers, joint ventures and competitive analysis in the  industry. All the market aspects are estimated and analysed by a team of innovative, enthusiastic and motivated researchers and analysts so that nothing lefts uncovered in the report. Global Epstein-Barr Virus Drug Market research report, it becomes easy to figure out brand awareness and insight about the brand and product among potential customers.

Epstein–Barr virus-associated Lymphomas and Others), Treatment Type (Preventive Treatment, Symptomatic Treatment and Others), Drugs (Acyclovir, Leflunomide/ Teriflunomide and Others), Route of Administration (Oral, Parenteral and Others), End Users (Hospitals, Homecare, Specialty Clinics and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Access Full 350 Pages PDF Report @

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Epstein-Barr Virus Drug Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Epstein-Barr Virus Drug Market.

Global Epstein-Barr Virus Drug Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players and brands that range from developments, products launches, acquisitions, mergers, joint ventures, trending innovation and business policies.

The following are the regions covered in this report.

North America [U.S., Canada, Mexico]

Europe [Germany, UK, France, Italy, Rest of Europe]

Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]

South America [Brazil, Argentina, Rest of Latin America]

The Middle East & Africa [GCC, North Africa, South Africa, Rest of the Middle East and Africa]

This study answers to the below key questions:

What are the key factors driving the Epstein-Barr Virus Drug Market?

What are the challenges to market growth?

Who are the key players in the Epstein-Barr Virus Drug Market?

What are the market opportunities and threats faced by the key players?

The major players covered in the Epstein-Barr virus drug market report are GlaxoSmithKline plc, Bristol-Myers Squibb Company, Novo Nordisk A/S, B. Braun Melsungen AG, AstraZeneca, Atara Biotherapeutics, Inc., Biotron Limited, Kuur Therapeutics., EUTILEX., Genocea, Lion TCR Pte. Ltd., Omeros Corporation, ViroStatics, Vironika, LLC, AlloVir, Tessa Therapeutics Ltd.., Viracta Therapeutics, Inc., Seagen Inc., Biogen., Amgen Inc., Gilead Sciences, Inc., and Incyte. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse Trending Reports:

Medical Clothing Market Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus https://www.databridgemarketresearch.com/reports/global-medical-clothing-market

Healthcare Facilities Management Market Size, Share, Trends, Industry Growth and Competitive Analysis https://www.databridgemarketresearch.com/reports/global-healthcare-facilities-management-market

Telehealth Market Size, Share, Trends, Growth Opportunities and Competitive Outlook https://www.databridgemarketresearch.com/reports/global-telehealth-market

Digital Health Technologies Market Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook https://www.databridgemarketresearch.com/reports/global-digital-health-technologies-market

Active Pharmaceutical Ingredient Api Market Size, Share, Key Drivers, Trends, Challenges and Competitive Analysis https://www.databridgemarketresearch.com/reports/global-active-pharmaceutical-ingredient-api-market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com

[drclaudiosaracinodcsworld]

EPSTEIN-BARR VS STANCHEZZA CRONICA?

VIRUS DI EPSTEIN-BARR STANCHEZZA CRONICA E SOLUZIONI INSOLITE? Il Potere dell’Ipnosi Professionale nella Lotta Contro il Virus di Epstein: Un Approccio Innovativo alla Cura Il virus di Epstein-Barr è una infezione virale comune che può causare una serie di sintomi, tra cui stanchezza cronica, mal di gola e gonfiore dei linfonodi. Tuttavia, grazie all’ipnosi vera e professionale, molte persone…

[willowreader]

Click on this link on a hopeful article for a vaccination against Multiple Sclerosis.

[vague-humanoid]

@startorrent02 @quasi-normalcy

Abstract

We assessed the distribution of SARS-CoV-2 at autopsy in 22 deceased persons with confirmed COVID-19. SARS-CoV-2 was found by PCR (2/22, 9.1%) and by culture (1/22, 4.5%) in skull sawdust, suggesting that live virus is present in tissues postmortem, including bone. Occupational exposure risk is low with appropriate personal protective equipment.

COVID autopsies also show evidence of the SARS-CoV-2 virus persisting throughout the body, including in the colon, the thorax, muscles, nerves, the reproductive tract, and the eye. In some cases, remnants of the virus showed up in the brain of a deceased patient 230 days after their first initial symptoms.

Some studies even suggest an infection of the SARS-CoV-2 virus can 'reawaken' other dormant viruses in the body, like the Epstein barr virus, which has been linked to chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).

[lotus-tower]

[ID:

The virus responsible for the Spanish flu set the stage for a wave of Parkinson’s disease decades later. People born during that pandemic had a threefold increased risk of later developing Parkinson’s.

The Epstein-Barr virus, once called the kissing disease, can lead to cancer, diabetes or multiple sclerosis decades later. An innocent flu-like infection can later erupt into a debilitating condition known as myalgic encephalomyelitis/chronic fatigue syndrome. And so on.

“The idea that a virus that produces acute infections can also cause chronic disease is not new. We just ignored it for 100 years,” said Al-Aly.

End ID]

Why So Quiet about Long Covid?

[5poder]

Moderna inaugura en Madrid su primer laboratorio de calidad fuera de EEUU para desarrollar vacunas ARNm

La compañía Moderna ha inaugurado en Madrid su primer laboratorio de Ensayos de Calidad de Vacunas ARN mensajero fuera de Estados Unidos. Un paso decisivo donde se muestra el interés de las grandes farmacéuticas por España, uno de los principales países donde más ensayos clínicos se llevan a cabo del mundo. Este Centro Internacional de Excelencia Analítica, el primero que testará sus vacunas en…

[transgriffin]

^^^ thank you for adding sources. The first is actually one that I consulted before writing the post.

I finally got some energy to fetch mine, adding them below (German):

(News article, not a research paper)

Robert-Koch-Institut:

PSA: If you had Epstein-Barr at any point in your life, and a Covid-19 infection later on, pay attention to the state of your daily spoons, energy, and attentive capabilities 3 months later.

I had Epstein-Barr 9 years ago, and Covid at the end of May. It is now mid-August and I am exhausted, confused, in a constant daze, brain-fogged, and my ADHD symptoms, especially executive dysfunction, are worse than ever.

Covid can reactivate Epstein-Barr viruses, and the viral load is well-measurable 3 months post-Covid, as far as I have gathered from a German source.

I'm going to ask to get tested for my current Epstein-Barr viral load.

Stay safe, everyone. I got that fuck-ass shit Covid virus in May 2024, when everyone was confidently parroting how "Covid is over". And that despite routinely washing my hands and masking in public transport.

I am 99,9% sure that I am dealing with Long Covid here.

I hate everything right now.

Get boostered if you can.

[covid-safer-hotties]

Also preserved on our archive

Not covid specific, but good to remember: Masking and other airborne disease prevention keeps you from getting other diseases like the flu too. Covid's not the only threat to your long-term health out there.

By Felicity Nelson

A study of around 500,000 medical records suggested that severe viral infections like encephalitis and pneumonia increase the risk of neurodegenerative diseases like Parkinson's and Alzheimer's.

Researchers found 22 connections between viral infections and neurodegenerative conditions in the study of around 450,000 people.

People treated for a type of inflammation of the brain called viral encephalitis were 31 times more likely to develop Alzheimer's disease. (For every 406 viral encephalitis cases, 24 went on to develop Alzheimer's disease – around 6 percent.)

Those who were hospitalized with pneumonia after catching the flu seemed to be more susceptible to Alzheimer's disease, dementia, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

Intestinal infections and meningitis (both often caused by a virus), as well as the varicella-zoster virus, which causes shingles, were also implicated in the development of several neurodegenerative diseases.

The impact of viral infections on the brain persisted for up to 15 years in some cases. And there were no instances where exposure to viruses was protective.

Around 80 percent of the viruses implicated in brain diseases were considered 'neurotrophic', which means they could cross the blood-brain barrier.

"Strikingly, vaccines are currently available for some of these viruses, including influenza, shingles (varicella-zoster), and pneumonia," the researchers wrote in their paper published last year.

"Although vaccines do not prevent all cases of illness, they are known to dramatically reduce hospitalization rates. This evidence suggests that vaccination may mitigate some risk of developing neurodegenerative disease."

In 2022, a study of more than 10 million people linked the Epstein-Barr virus with a 32-fold increased risk of multiple sclerosis.

"After reading [this] study, we realized that for years scientists had been searching – one-by-one – for links between an individual neurodegenerative disorder and a specific virus," said senior author Michael Nalls, a neurogeneticist at the National Institute on Aging in the US.

"That's when we decided to try a different, more data science-based approach," he said. "By using medical records, we were able to systematically search for all possible links in one shot."

First, the researchers analyzed the medical records of around 35,000 Finns with six different types of neurodegenerative diseases and compared this against a group of 310,000 controls who did not have a brain disease.

This analysis yielded 45 links between viral exposure and neurodegenerative diseases, and this was narrowed down to 22 links in a subsequent analysis of 100,000 medical records from the UK Biobank.

While this retrospective observational study cannot demonstrate a causal link, it adds to the pile of research hinting at the role of viruses in Parkinson's and Alzheimer's disease.

"Neurodegenerative disorders are a collection of diseases for which there are very few effective treatments and many risk factors," said co-author Andrew Singleton, a neurogeneticist and Alzheimer's researcher and the director of the Center for Alzheimer's and Related Dementias.

"Our results support the idea that viral infections and related inflammation in the nervous system may be common – and possibly avoidable – risk factors for these types of disorders."

This study was published in Neuron.

Study link: www.cell.com/neuron/fulltext/S0896-6273(22)01147-3?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627322011473%3Fshowall%3Dtrue

[transmutationisms]

these tags annoyed me to be honest

1. PCOS is a bad point of comparison because despite the name, diagnosis is not *supposed to be* done on the primary basis of finding cysts in the ovaries; these are common and not inherently of concern. instead, the more indicative biomarker is the hormone test (high levels of testosterone *throughout the menstrual period*, with corresponding disruption to the expected/typical fluctuations in estrogen/progesterone) but often diagnosis is done more on the basis of a physical exam ('exam') confirming characteristics such as hairiness or adiposity. this absolutely DOES result in PCOS overdiagnosis for some demographics; while a real biological condition, PCOS is also a load-bearing diagnostic term in the enforcement of very specific standards of (white) femininity and its use also frequently masks, for example, the frequency of hypothalamic amenorrhea (HA) secondary to chronic energy deficiency (as in anorexia), which doctors are loathe to diagnose because they view weight loss as prima facie good

2. the reason it matters that psychiatric diagnoses do not have a 'biology' is not because every disease must have a single specific biomarker; it is correct that some do not. however, the way patient complaints are sifted into categories labelled 'psychiatric' versus '(otherwise) medical' begins essentially with determining whether the distress is 'physical' or 'mental'. in other words, in the case of, say, the chronic fatigue syndrome (famously, lacking a known specific biomarker), the symptoms being investigated by the non-psychiatrist physician are still physical (PEM; mast cell dysregulation; pain; etc) whereas a diagnosis of depression may be accompanied by, but requires no, physical symptoms or presentation. the psychiatric claim that its diagnoses have biological causes and correlates is specifically a claim about the role of neurobiology in the causation of affective states; thus, the comparison to physical complaints is meaningless here

3. this person goes on to claim that depressives do in fact share, though not universally, certain biomarkers such as mitochondrial dysregulations. such claims typically come from various imaging studies plagued with systemic problems in the selection and definition of patient populations as well as the subjectivity of result interpretation and analysis. these claims are not well supported and typically rely on circular selection and definition of patient populations

4. speaking philosophically, it is in fact often correct to challenge the notion that a physical 'disease' chronically lacking a specific biomarker is indeed a disease, in any sense besides the colloquial one. that is, diseases that cannot be correlated with one cause or presentation are often better understood as 'syndromes', which is to say, as a taxonomical heuristic that is likely grouping together multiple disparate physical (anatomical, physiological, functional, &c) problems with multiple disparate causes. this is almost certainly the case for chronic fatigue syndrome, for example. this is a philosophical distinction that matters for research and understanding, and does not mean or imply anything to minimise or contradict the patient experience of the syndrome or symptoms. it matters because, for instance, CFS triggered by the epstein-barr virus may indeed turn out to have different disease mechanisms to CFS triggered by, say, covid-19, or may have different specific mechanisms when running in certain families, and so on. distinguishing these much more specific presentations, and possibly distinct diseases, from the current discursive schema of the overlying syndrome is potentially very good for patients, who likely have different needs and treatments to one another despite currently all sharing the same label in their charts

5. which goes back to an overlying point, which is that (despite frequent defensiveness to the contrary), whether or not something is a disease does not inherently tell us anything about its reality, its severity, its cause, the moral status of its sufferers, &c